Guide to anticoagulant therapy. Part 2: Oral anticoagulants. American Heart Association.
1994; Lippincott Williams & Wilkins; Volume: 89; Issue: 3 Linguagem: Inglês
10.1161/01.cir.89.3.1469
ISSN1524-4539
Autores Tópico(s)Blood Pressure and Hypertension Studies
ResumoHomeCirculationVol. 89, No. 3Guide to anticoagulant therapy. Part 2: Oral anticoagulants. American Heart Association. Free AccessAbstractPDF/EPUBAboutView PDFSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessAbstractPDF/EPUBGuide to anticoagulant therapy. Part 2: Oral anticoagulants. American Heart Association. J Hirsh and V Fuster J HirshJ Hirsh Office of Scientific Affairs, American Heart Association, Dallas, TX 75231-4596. and V FusterV Fuster Office of Scientific Affairs, American Heart Association, Dallas, TX 75231-4596. Originally published1 Mar 1994https://doi.org/10.1161/01.CIR.89.3.1469Circulation. 1994;89:1469–1480 Previous Back to top Next FiguresReferencesRelatedDetailsCited ByHeidenreich P, Estes N, Fonarow G, Jurgens C, Kittleson M, Marine J, McManus D and McNamara R (2020) 2020 Update to the 2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures, Circulation: Cardiovascular Quality and Outcomes, 14:1, Online publication date: 1-Jan-2021. Heidenreich P, Estes N, Fonarow G, Jurgens C, Kittleson M, Marine J, McManus D and McNamara R (2021) 2020 Update to the 2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter, Journal of the American College of Cardiology, 10.1016/j.jacc.2020.08.037, 77:3, (326-341), Online publication date: 1-Jan-2021. January C, Wann L, Calkins H, Chen L, Cigarroa J, Cleveland J, Ellinor P, Ezekowitz M, Field M, Furie K, Heidenreich P, Murray K, Shea J, Tracy C and Yancy C (2019) 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation, Heart Rhythm, 10.1016/j.hrthm.2019.01.024, 16:8, (e66-e93), Online publication date: 1-Aug-2019. January C, Wann L, Calkins H, Chen L, Cigarroa J, Cleveland J, Ellinor P, Ezekowitz M, Field M, Furie K, Heidenreich P, Murray K, Shea J, Tracy C and Yancy C (2019) 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons, Circulation, 140:2, (e125-e151), Online publication date: 9-Jul-2019. January C, Wann L, Calkins H, Chen L, Cigarroa J, Cleveland J, Ellinor P, Ezekowitz M, Field M, Furie K, Heidenreich P, Murray K, Shea J, Tracy C and Yancy C (2019) 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation, Journal of the American College of Cardiology, 10.1016/j.jacc.2019.01.011, 74:1, (104-132), Online publication date: 1-Jul-2019. Michida M, Ishikawa H, Kaneda T, Tatekabe S and Nakamura Y (2019) Development of an Efficient Manufacturing Process for a Key Intermediate in the Synthesis of Edoxaban, Organic Process Research & Development, 10.1021/acs.oprd.8b00413, 23:4, (524-534), Online publication date: 19-Apr-2019. Michida M (2018) Development of Efficient Manufacturing Method for Key Intermediate of Edoxaban経口FXa阻害薬Edoxaban中間体の効率的合成法の開発, Journal of Synthetic Organic Chemistry, Japan, 10.5059/yukigoseikyokaishi.76.1332, 76:12, (1332-1340), Online publication date: 1-Dec-2018. Haghighi A, Finder R and Bennett J (2016) Systemic Disease and Bleeding Disorders for the Oral and Maxillofacial Surgeon, Oral and Maxillofacial Surgery Clinics of North America, 10.1016/j.coms.2016.06.004, 28:4, (461-471), Online publication date: 1-Nov-2016. Heidenreich P, Solis P, Estes N, Fonarow G, Jurgens C, Marine J, McManus D and McNamara R (2016) 2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter, Journal of the American College of Cardiology, 10.1016/j.jacc.2016.03.521, 68:5, (525-568), Online publication date: 1-Aug-2016. Heidenreich P, Solis P, Mark Estes N, Fonarow G, Jurgens C, Marine J, McManus D and McNamara R (2016) 2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter, Circulation: Cardiovascular Quality and Outcomes, 9:4, (443-488), Online publication date: 1-Jul-2016. Dong M, Chen H, Ren Y and Shao F (2016) Molecular modeling studies, synthesis and biological evaluation of dabigatran analogues as thrombin inhibitors, Bioorganic & Medicinal Chemistry, 10.1016/j.bmc.2015.11.025, 24:2, (73-84), Online publication date: 1-Jan-2016. Alparslan M and Danış Ö (2015) In Vitro Inhibition of Human Placental Glutathione S -Transferase by 3-Arylcoumarin Derivatives , Archiv der Pharmazie, 10.1002/ardp.201500151, 348:9, (635-642), Online publication date: 1-Sep-2015. He L, Dai W and Li N (2015) Development of Orally Active Thrombin Inhibitors for the Treatment of Thrombotic Disorder Diseases, Molecules, 10.3390/molecules200611046, 20:6, (11046-11062) January C, Wann L, Alpert J, Calkins H, Cigarroa J, Cleveland J, Conti J, Ellinor P, Ezekowitz M, Field M, Murray K, Sacco R, Stevenson W, Tchou P, Tracy C and Yancy C (2014) 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation, Circulation, 130:23, (e199-e267), Online publication date: 2-Dec-2014.January C, Wann L, Alpert J, Calkins H, Cigarroa J, Cleveland J, Conti J, Ellinor P, Ezekowitz M, Field M, Murray K, Sacco R, Stevenson W, Tchou P, Tracy C and Yancy C (2014) 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary, Circulation, 130:23, (2071-2104), Online publication date: 2-Dec-2014. January C, Wann L, Alpert J, Calkins H, Cigarroa J, Cleveland J, Conti J, Ellinor P, Ezekowitz M, Field M, Murray K, Sacco R, Stevenson W, Tchou P, Tracy C and Yancy C (2014) 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation, Journal of the American College of Cardiology, 10.1016/j.jacc.2014.03.022, 64:21, (e1-e76), Online publication date: 1-Dec-2014. January C, Wann L, Alpert J, Calkins H, Cigarroa J, Cleveland J, Conti J, Ellinor P, Ezekowitz M, Field M, Murray K, Sacco R, Stevenson W, Tchou P, Tracy C and Yancy C (2014) 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary, Journal of the American College of Cardiology, 10.1016/j.jacc.2014.03.021, 64:21, (2246-2280), Online publication date: 1-Dec-2014. Shi Z, Li N, Tang Y and Duan J (2014) Prolinamide derivatives as thrombin inhibitors for the treatment of thrombin-mediated diseases: a patent evaluation of US2013296245, Expert Opinion on Therapeutic Patents, 10.1517/13543776.2014.959493, 24:10, (1139-1148), Online publication date: 1-Oct-2014. Qi X, Han G and Fan D (2014) Management of portal vein thrombosis in liver cirrhosis, Nature Reviews Gastroenterology & Hepatology, 10.1038/nrgastro.2014.36, 11:7, (435-446), Online publication date: 1-Jul-2014. Chetlen A, Kasales C, Mack J, Schetter S and Zhu J (2013) Hematoma Formation During Breast Core Needle Biopsy in Women Taking Antithrombotic Therapy, American Journal of Roentgenology, 10.2214/AJR.12.9930, 201:1, (215-222), Online publication date: 1-Jul-2013. Bivard A, Lin L and Parsonsb M (2013) Review of Stroke Thrombolytics, Journal of Stroke, 10.5853/jos.2013.15.2.90, 15:2, (90), . Hagihara Y, Ueno M, Mizushima Y and Matsuoka T (2013) A classification for blunt cerebrovascular injury based on the zone of its occurrence: the application to the therapeutic strategy, Nihon Kyukyu Igakukai Zasshi, 10.3893/jjaam.24.157, 24:3, (157-165), . FOX K, WHITE H, GERSH B and OPIE L (2013) Antithrombotic agents: Platelet inhibitors, acute anticoagulants, fibrinolytics, and chronic anticoagulants Drugs for the Heart, 10.1016/B978-1-4557-3322-4.00018-1, (332-397), . Mehta S and Kleiman N (2013) Unstable Angina and Non-ST Segment Elevation Myocardial Infarction (Acute Coronary Syndromes) Essential Cardiology, 10.1007/978-1-4614-6705-2_25, (439-457), . Kimmel S and Troxel A (2012) Novel incentive-based approaches to adherence, Clinical Trials, 10.1177/1740774512453520, 9:6, (689-695), Online publication date: 1-Dec-2012. Hill A and Pacheco L (2012) Cardiovascular Disease in Pregnancy, NeoReviews, 10.1542/neo.13-11-e651, 13:11, (e651-e660), Online publication date: 1-Nov-2012. Eichhorn W, Burkert J, Vorwig O, Blessmann M, Cachovan G, Zeuch J, Eichhorn M and Heiland M (2011) Bleeding incidence after oral surgery with continued oral anticoagulation, Clinical Oral Investigations, 10.1007/s00784-011-0649-1, 16:5, (1371-1376), Online publication date: 1-Oct-2012. Ioannidis O, Paraskevas G, Kotronis A, Chatzopoulos S, Konstantara A, Papadimitriou N, Makrantonakis A and Kakoutis E (2015) Surgical Management of Severe Spontaneous Hemorrhage of the Abdominal Wall Complicating Acenocoumarol Treatment, Acta Medica (Hradec Kralove, Czech Republic), 10.14712/18059694.2015.75, 55:1, (47-49), . ten Cate H (2017) Monitoring new oral anticoagulants, managing thrombosis, or both?, Thrombosis and Haemostasis, 10.1160/TH12-03-0130, 107:05, (803-805), . Khattab A, Windecker S, Jüni P, Hildick-Smith D, Dudek D, Andersen H, Ibrahim R, Schuler G, Walton A, Wahl A, Mattle H and Meier B (2011) Randomized clinical trial comparing percutaneous closure of patent foramen ovale (PFO) using the Amplatzer PFO Occluder with medical treatment in patients with cryptogenic embolism (PC-Trial): rationale and design, Trials, 10.1186/1745-6215-12-56, 12:1, Online publication date: 1-Dec-2011. Moualla H and Garcia D (2011) Vitamin K Antagonists – Current Concepts and Challenges, Thrombosis Research, 10.1016/j.thromres.2011.04.011, 128:3, (210-215), Online publication date: 1-Sep-2011. KOSYFAKI P, ATT W and STRUB J (2010) The dental patient on oral anticoagulant medication: a literature review, Journal of Oral Rehabilitation, 10.1111/j.1365-2842.2010.02184.x, 38:8, (615-633), Online publication date: 1-Aug-2011. Gallus A (2011) Oral anticoagulants Coronary Care Manual, 10.1016/B978-0-7295-3927-2.10043-0, (319-327), . Zhang J and Crawford J (2010) Rivaroxaban (Xarelto): A Factor Xa Inhibitor for the Treatment of Thrombotic Events Modern Drug Synthesis, 10.1002/9780470768594.ch14, (191-205) Fujimoto T, Imaeda Y, Konishi N, Hiroe K, Kawamura M, Textor G, Aertgeerts K and Kubo K (2010) Discovery of a Tetrahydropyrimidin-2(1 H )-one Derivative (TAK-442) as a Potent, Selective, and Orally Active Factor Xa Inhibitor , Journal of Medicinal Chemistry, 10.1021/jm901699j, 53:9, (3517-3531), Online publication date: 13-May-2010. Pastore F, Losi M, Carpinella G, Cavallaro M, Fundaliotis A, Chiacchio E, Betocchi S and Chiariello M (2009) Thrombosis of mechanical valve prosthesis in patient with recent Caesarean delivery, European Heart Journal - Cardiovascular Imaging, 10.1093/ejechocard/jep046, 10:5, (716-717), Online publication date: 1-Jul-2009., Online publication date: 1-Jul-2009. Nagata T, Yoshino T, Haginoya N, Yoshikawa K, Nagamochi M, Kobayashi S, Komoriya S, Yokomizo A, Muto R, Yamaguchi M, Osanai K, Suzuki M and Kanno H (2009) Discovery of N-[(1R,2S,5S)-2-{[(5-chloroindol-2-yl)carbonyl]amino}-5-(dimethylcarbamoyl)cyclohexyl]-5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxamide hydrochloride: A novel, potent and orally active direct inhibitor of factor Xa, Bioorganic & Medicinal Chemistry, 10.1016/j.bmc.2008.12.037, 17:3, (1193-1206), Online publication date: 1-Feb-2009. Hagihara Y, Ueno M, Yamamoto A, Mizushima Y, Ishikawa K and Matsuoka T (2009) Blunt cerebrovascular injury and its therapeutic strategy: importance and efficiency of endovascular therapy, Nihon Kyukyu Igakukai Zasshi, 10.3893/jjaam.20.212, 20:4, (212-220), . FOX K, WHITE H, OPIE J, GERSH B and OPIE L (2009) Antithrombotic Agents: Platelet Inhibitors, Anticoagulants, and Fibrinolytics Drugs for the Heart, 10.1016/B978-1-4160-6158-8.50014-9, (293-340), . Blanchard D and Shabetai R (2009) Cardiac Diseases Creasy and Resnik's Maternal-Fetal Medicine: Principles and Practice, 10.1016/B978-1-4160-4224-2.50042-9, (797-824), . Harnett M and Tsen L (2009) Cardiovascular Disease Chestnut's Obstetric Anesthesia: Principles and Practice, 10.1016/B978-0-323-05541-3.00041-7, (881-912), . Bonow R, Carabello B, Chatterjee K, de Leon A, Faxon D, Freed M, Gaasch W, Lytle B, Nishimura R, O'Gara P, O'Rourke R, Otto C, Shah P, Shanewise J, Nishimura R, Carabello B, Faxon D, Freed M, Lytle B, O'Gara P, O'Rourke R and Shah P (2008) 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease, Journal of the American College of Cardiology, 10.1016/j.jacc.2008.05.007, 52:13, (e1-e142), Online publication date: 1-Sep-2008. Nakai K, Tsuboi J, Okabayashi H, Fukuhiro Y, Oka T, Habano W, Fukushima N, Nakai K, Obara W, Fujioka T, Suwabe A and Gurwitz D (2007) Ethnic differences in the VKORC1 gene polymorphism and an association with warfarin dosage requirements in cardiovascular surgery patients , Pharmacogenomics, 10.2217/14622416.8.7.713, 8:7, (713-719), Online publication date: 1-Jul-2007. Sconce E and Kamali F (2006) Appraisal of current vitamin K dosing algorithms for the reversal of over-anticoagulation with warfarin: the need for a more tailored dosing regimen, European Journal of Haematology, 10.1111/j.0902-4441.2006.t01-1-EJH2957.x, 77:6, (457-462), Online publication date: 1-Dec-2006. Miura M, Seki N, Koike T, Ishihara T, Niimi T, Hirayama F, Shigenaga T, Sakai-Moritani Y, Kawasaki T, Sakamoto S, Okada M, Ohta M and Tsukamoto S (2006) Potent and selective TF/FVIIa inhibitors containing a neutral P1 ligand, Bioorganic & Medicinal Chemistry, 10.1016/j.bmc.2006.08.010, 14:23, (7688-7705), Online publication date: 1-Dec-2006. Saw J, Bahari M, Ang H and Lim Y (2006) Potential drug–herb interaction with antiplatelet/anticoagulant drugs, Complementary Therapies in Clinical Practice, 10.1016/j.ctcp.2006.06.002, 12:4, (236-241), Online publication date: 1-Nov-2006. Konagai N, Uchimura N, Nakamura K and Kudo T (2006) Evaluation of coagulant activity after mechanical heart valve replacement, Journal of Artificial Organs, 10.1007/s10047-006-0339-y, 9:3, (161-164), Online publication date: 29-Sep-2006. (2006) ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: Executive Summary, Circulation, 114:5, (450-527), Online publication date: 1-Aug-2006.Bonow R, Carabello B, Chatterjee K, de Leon A, Faxon D, Freed M, Gaasch W, Lytle B, Nishimura R, O'Gara P, O'Rourke R, Otto C, Shah P and Shanewise J (2006) ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease, Circulation, 114:5, (e84-e231), Online publication date: 1-Aug-2006. Bonow R, Carabello B, Chatterjee K, de Leon A, Faxon D, Freed M, Gaasch W, Lytle B, Nishimura R, O'Gara P, O'Rourke R, Otto C, Shah P, Shanewise J, Smith S, Jacobs A, Adams C, Anderson J, Antman E, Faxon D, Fuster V, Halperin J, Hiratzka L, Hunt S, Lytle B, Nishimura R, Page R and Riegel B (2006) ACC/AHA 2006 Practice Guidelines for the Management of Patients With Valvular Heart Disease: Executive Summary, Journal of the American College of Cardiology, 10.1016/j.jacc.2006.05.030, 48:3, (598-675), Online publication date: 1-Aug-2006. Bonow R, Carabello B, Chatterjee K, de Leon A, Faxon D, Freed M, Gaasch W, Lytle B, Nishimura R, O'Gara P, O'Rourke R, Otto C, Shah P, Shanewise J, Smith S, Jacobs A, Adams C, Anderson J, Antman E, Faxon D, Fuster V, Halperin J, Hiratzka L, Hunt S, Lytle B, Nishimura R, Page R and Riegel B (2006) ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease, Journal of the American College of Cardiology, 10.1016/j.jacc.2006.05.021, 48:3, (e1-e148), Online publication date: 1-Aug-2006. Ding Y and Clark J (2013) Cerebrovascular injury in stroke, Neurological Research, 10.1179/016164106X91799, 28:1, (3-10), Online publication date: 1-Jan-2006. (2006) Standard Angiographic and Interventional Techniques Vascular and Interventional Radiology, 10.1016/B978-0-7216-0621-7.50007-X, (15-48), . Atmakuri S and Kleiman N Unstable Angina and Non-ST Segment Elevation Myocardial Infarction (Acute Coronary Syndromes) Essential Cardiology, 10.1007/978-1-59259-918-9_26, (471-487) Stroud L, Mamdani M, Kopp A and Bell C (2005) The safety of levofloxacin in elderly patients on warfarin, The American Journal of Medicine, 10.1016/j.amjmed.2005.06.066, 118:12, (1417.e7-1417.e12), Online publication date: 1-Dec-2005. Komoriya S, Haginoya N, Kobayashi S, Nagata T, Mochizuki A, Suzuki M, Yoshino T, Horino H, Nagahara T, Suzuki M, Isobe Y and Furugoori T (2005) Design, synthesis, and biological activity of non-basic compounds as factor Xa inhibitors: SAR study of S1 and aryl binding sites, Bioorganic & Medicinal Chemistry, 10.1016/j.bmc.2005.04.006, 13:12, (3927-3954), Online publication date: 1-Jun-2005. Srivastava S, Goswami L and Dikshit D (2005) Progress in the design of low molecular weight thrombin inhibitors, Medicinal Research Reviews, 10.1002/med.20016, 25:1, (66-92), Online publication date: 1-Jan-2005. Yetkin U, Karabay Ö and Önol H (2004) Effects of oral anticoagulation with various INR levels in deep vein thrombosis cases, Current Controlled Trials in Cardiovascular Medicine, 10.1186/1468-6708-5-1, 5:1, Online publication date: 1-Dec-2004. Schurgers L, Shearer M, Hamulyák K, Stöcklin E and Vermeer C (2004) Effect of vitamin K intake on the stability of oral anticoagulant treatment: dose-response relationships in healthy subjects, Blood, 10.1182/blood-2004-04-1525, 104:9, (2682-2689), Online publication date: 1-Nov-2004. Yang D, Robetorye R and Rodgers G (2004) Home prothrombin time monitoring: A literature analysis, American Journal of Hematology, 10.1002/ajh.20161, 77:2, (177-186), Online publication date: 1-Oct-2004. Karabay O, Yetkin U and Onol H (2004) Upper Extremity Deep Vein Thrombosis: Clinical and Treatment Characteristics, Journal of International Medical Research, 10.1177/147323000403200413, 32:4, (429-435), Online publication date: 1-Aug-2004. Tunali T, Yarat A, Bulut M and Emekli N (2004) 6,7-Dihydroxy-3-phenylcoumarin inhibits thromboplastin induced disseminated intravascular coagulation, British Journal of Haematology, 10.1111/j.1365-2141.2004.05033.x, 126:2, (226-230), Online publication date: 1-Jul-2004. Califf R (2004) Watching the WATCH trial: the role of sponsors and data monitoring committees, Journal of Cardiac Failure, 10.1016/j.cardfail.2004.03.001, 10:2, (113-114), Online publication date: 1-Apr-2004. Bubenheimer P (2004) Pulmonale Hypertonie — Cor pulmonale Herzkrankheiten, 10.1007/978-3-642-18649-3_60, (1201-1216), . Skerman J and Rajab K Emboli in Pregnancy Anesthetic and Obstetric Management of High-Risk Pregnancy, 10.1007/0-387-21572-7_24, (347-367) Pengo V, Barbero F, Biasiolo A, Pegoraro C, Cucchini U and Iliceto S (2003) A Comparison Between Six- and Four-Week Intervals in Surveillance of Oral Anticoagulant Treatment, American Journal of Clinical Pathology, 10.1309/U7164E0XH5UERKRV, 120:6, (944-947), Online publication date: 1-Dec-2003. Lockhart P, Gibson J, Pond S and Leitch J (2003) Dental management considerations for the patient with an acquired coagulopathy. Part 2: Coagulopathies from drugs, British Dental Journal, 10.1038/sj.bdj.4810660, 195:9, (495-500), Online publication date: 1-Nov-2003. Rittle K, Barrow J, Cutrona K, Glass K, Krueger J, Kuo L, Lewis S, Lucas B, McMasters D, Morrissette M, Nantermet P, Newton C, Sanders W, Yan Y, Vacca J and Selnick H (2003) Unexpected enhancement of thrombin inhibitor potency with o -aminoalkylbenzylamides in the P1 position, Bioorganic & Medicinal Chemistry Letters, 10.1016/S0960-894X(03)00732-7, 13:20, (3477-3482), Online publication date: 1-Oct-2003. Karki S and Lander S (2016) Evaluation of Anticoagulation Therapy in an Academic Nursing Home, Journal of Pharmacy Technology, 10.1177/875512250301900402, 19:4, (141-145), Online publication date: 1-Jul-2003. Brennan M, Shariff G, Kent M, Fox P and Lockhart P (2002) Relationship between bleeding time test and postextraction bleeding in a healthy control population, Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 10.1067/moe.2002.125581, 94:4, (439-443), Online publication date: 1-Oct-2002. Chiang C, Chu P and Hsu L (2002) Intra-atrial thrombolytic therapy for dissolution of chronic left atrial thrombi in patients undergoing balloon mitral commissurotomy, Catheterization and Cardiovascular Interventions, 10.1002/ccd.10256, 56:4, (460-465), Online publication date: 1-Aug-2002. Bogousslavsky J and Moncayo-Gaete J (2002) Prognosis After Stroke Long-Term Effects of Stroke, 10.1201/9780203908884.ch4, Online publication date: 21-Jun-2002. Little J, Miller C, Henry R and McIntosh B (2002) Antithrombotic agents: Implications in dentistry, Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 10.1067/moe.2002.121391, 93:5, (544-551), Online publication date: 1-May-2002. Caro J, Getsios D, Caro I and O??Brien J (2002) Cost Effectiveness of Tinzaparin Sodium Versus Unfractionated Heparin in the Treatment of Proximal Deep Vein Thrombosis, PharmacoEconomics, 10.2165/00019053-200220090-00003, 20:9, (593-602), . Taube C (2002) Pharmaka mit Wirkung auf die Blutgerinnung Pharmakologie und Toxikologie, 10.1007/978-3-642-56314-0_25, (439-460), . Raj G and Morales C (2001) Management of anticoagulation for gastrointestinal endoscopic procedures, Current Treatment Options in Gastroenterology, 10.1007/s11938-001-0011-9, 4:6, (459-466), Online publication date: 1-Dec-2001. Brown D (2001) TREATMENT OPTIONS FOR DEEP VENOUS THROMBOSIS, Emergency Medicine Clinics of North America, 10.1016/S0733-8627(05)70226-1, 19:4, (913-924), Online publication date: 1-Nov-2001. Betz A (2005) Recent advances in Factor Xa inhibitors, Expert Opinion on Therapeutic Patents, 10.1517/13543776.11.6.1007, 11:6, (1007-1017), Online publication date: 1-Jun-2001. Aldous J and Olson C (2001) Managing patients on warfarin therapy: a case report, Special Care in Dentistry, 10.1111/j.1754-4505.2001.tb00236.x, 21:3, (109-112), Online publication date: 1-May-2001. Yuan S and Guo J (2001) Subsequent intracranial haemorrhage following open heart surgery, Annals of the College of Surgeons of Hong Kong, 10.1046/j.1442-2034.2001.00101.x, 5:2, (66-73), Online publication date: 1-May-2001. Grau E, Tenias J, Real E, Medrano J, Ferrer R, Pastor E and Selfa S (2001) Home treatment of deep venous thrombosis with low molecular weight heparin: Long-term incidence of recurrent venous thromboembolism, American Journal of Hematology, 10.1002/ajh.1069, 67:1, (10-14), Online publication date: 1-May-2001. (2001) Point-of-Care Prothrombin Time Measurement for Professional and Patient Self-Testing Use, American Journal of Clinical Pathology, 10.1309/KM0J-G5V9-KCAG-CLEE, 115:2, (288-296), Online publication date: 1-Feb-2001. Yulong C Computer Application to the Laboratory Management in Hospital, Clinical Chemistry and Laboratory Medicine, 10.1515/CCLM.2001.195, 39:12 Agarwal A and Venugopalan P (2001) Left atrial spontaneous echo contrast in patients with rheumatic mitral valve stenosis in sinus rhythm: relationship to mitral valve and left atrial measurements, International Journal of Cardiology, 10.1016/S0167-5273(00)00415-0, 77:1, (63-68), Online publication date: 1-Jan-2001. Moulin T, Tatu L and Vuillier F (2001) Antithrombotic Therapy in Stroke Current Review of Cerebrovascular Disease, 10.1007/978-1-4684-0001-4_17, (183-196), . Gupta D, Kothari S, Bahl V, Goswami K, Talwar K, Manchanda S and Venugopal P (2000) Thrombolytic therapy for prosthetic valve thrombosis: Short- and long-term results, American Heart Journal, 10.1067/mhj.2000.111109, 140:6, (906-916), Online publication date: 1-Dec-2000. Superstein R, Gomolin J, Hammouda W, Rosenberg A, Overbury O and Arsenault C (2000) Prevalence of ocular hemorrhage in patients receiving warfarin therapy, Canadian Journal of Ophthalmology, 10.1016/S0008-4182(00)80126-X, 35:7, (385-389), Online publication date: 1-Dec-2000. Cho J, Seo H, Yun C, Koo B, Yoshida S, Koga T, Dan T and Kim H (2000) In Vitro and In Vivo Studies of AT-1362, a Newly Synthesized and Orally Active Inhibitor of Thrombin, Thrombosis Research, 10.1016/S0049-3848(00)00298-X, 100:1, (97-107), Online publication date: 1-Oct-2000. von Matt A, Ehrhardt C, Burkhard P, Metternich R, Walkinshaw M and Tapparelli C (2000) Selective boron-Containing thrombin inhibitors—X-ray analysis reveals surprising binding mode, Bioorganic & Medicinal Chemistry, 10.1016/S0968-0896(00)00147-4, 8:9, (2291-2303), Online publication date: 1-Sep-2000. Sra J, Dhala A, Blanck Z, Deshpande S, Cooley R and Akhtar M (2000) Atrial fibrillation: Epidemiology, mechanisms, and management, Current Problems in Cardiology, 10.1016/S0146-2806(00)80003-1, 25:7, (413-524), Online publication date: 1-Jul-2000. WAHL M (2000) MYTHS OF DENTAL SURGERY IN PATIENTS, The Journal of the American Dental Association, 10.14219/jada.archive.2000.0024, 131:1, (77-81), Online publication date: 1-Jan-2000. Azpitarte (coordinador) J, María Alonso Á, García Gallego F, González Santos J, Paré C and Tello A (2000) Guías de práctica clínica de la Sociedad Española de Cardiología en valvulopatías, Revista Española de Cardiología, 10.1016/S0300-8932(00)75227-4, 53:9, (1209-1278), Online publication date: 1-Jan-2000. Frishman W, Cheng-Lai A and Chen J (2000) Antithrombotic Therapy Current Cardiovascular Drugs, 10.1007/978-1-4615-6767-7_7, (85-119), . Martin M (2000) Acute Vein Thrombosis Textbook of Angiology, 10.1007/978-1-4612-1190-7_89, (1155-1180), . Grau E, Real E, Medrano J, Pastor E and Selfa S (1999) Recurrent Venous Thromboembolism in a Spanish Population, Thrombosis Research, 10.1016/S0049-3848(99)00121-8, 96:5, (335-341), Online publication date: 1-Dec-1999. Cannon C (1999) Diagnosis and management of patients with unstable angina, Current Problems in Cardiology, 10.1016/S0146-2806(99)90015-4, 24:11, (681-744), Online publication date: 1-Nov-1999. Peverill R (1999) 10. Warfarin or aspirin: both or others?, Medical Journal of Australia, 10.5694/j.1326-5377.1999.tb123671.x, 171:6, (321-326), Online publication date: 1-Sep-1999. Murayama N, Tanaka M, Kunitada S, Yamada H, Inoue T, Terada Y, Fujita M and Ikeda Y (1999) Tolerability, pharmacokinetics, and pharmacodynamics of DX-9065a, a new synthetic potent anticoagulant and specific factor Xa inhibitor, in healthy male volunteers, Clinical Pharmacology & Therapeutics, 10.1016/S0009-9236(99)70033-0, 66:3, (258-264), Online publication date: 1-Sep-1999. Windecker S and Meier B (1999) Percutaneous patent foramen ovale (PFO) closure: It can be done but should it?, Catheterization and Cardiovascular Interventions, 10.1002/(SICI)1522-726X(199907)47:3 3.0.CO;2-#, 47:3, (377-380), Online publication date: 1-Jul-1999. Jamieson W, Miyagishima R, Grunkemeier G, Germann E, Henderson C, Fradet G, Burr L and Lichtenstein S (1999) Bileaflet mechanical prostheses performance in mitral position, European Journal of Cardio-Thoracic Surgery, 10.1016/S1010-7940(99)00087-1, 15:6, (786-794), Online publication date: 1-Jun-1999., Online publication date: 1-Jun-1999. Al-Zahrani H, Bates S and Weitz J (1999) Deep vein thrombosis, Current Treatment Options in Cardiovascular Medicine, 10.1007/s11936-999-0006-8, 1:1, (43-53), Online publication date: 1-Mar-1999. Taube C (1999) Pharmaka mit Wirkung auf die Blutgerinnung Pharmakologie und Toxikologie, 10.1007/978-3-642-98030-5_26, (423-441), . Roldán V, Marín F, Marco P, Martínez J, Calatayud R and Sogorb F (1998) Hypofibrinolysis in atrial fibrillation, American Heart Journal, 10.1016/S0002-8703(98)70149-8, 136:6, (956-960), Online publication date: 1-Dec-1998. Villablanca A (2015) Heart disease during pregnancy, Postgraduate Medicine, 10.3810/pgm.1998.11.407, 104:5, (149-155), Online publication date: 1-Nov-1998. Bonow R, Carabello B, de Leon A, Edmunds L, Fedderly B, Freed M, Gaasch W, McKay C, Nishimura R, O'Gara P, O'Rourke R, Rahimtoola S, Ritchie J, Cheitlin M, Eagle K, Gardner T, Garson A, Gibbons R, O'Rourke R, Russell R, Ryan T and Smith S (1998) ACC/AHA guidelines for the management of patients with valvular heart disease, Journal of the American College of Cardiology, 10.1016/S0735-1097(98)00454-9, 32:5, (1486-1582), Online publication date: 1-Nov-1998. Chang R, Doherty T and Goldberg S (1998) How does warfarin affect the activated coagulation time?, American Heart Journal, 10.1016/S0002-8703(98)70223-6, 136:3, (477-479), Online publication date: 1-Sep-1998. Nevarre D and Digiovanni A (1998) Hypercoagulability and the Management of Anticoagulant Therapy in Surgical Patients: Review and Recommendations, Journal of Endovascular Surgery, 10.1583/1074-6218(1998)005 2.0.CO;2, 5:3, (282-291), Online publication date: 1-Aug-1998. Nevarre D and Digiovanni A (2016) Hypercoagulability and the Management of Anticoagulant Therapy in Surgical Patients: Review and Recommendations, Journal of Endovascular Therapy, 10.1177/152660289800500319, 5:3, (282-291), Online publication date: 1-Aug-1998. Harbrecht , Oldenburg , Klein , Weber , Rockstroh and Hanfland (2002) Increased sensitivity of factor IX to phenprocoumon as a cause of bleeding in a patient with antiphospholipid antibody associated thrombosis, Journal of Internal Medicine, 10.1046/j.1365-2796.1998.00252.x, 243:1, (73-77), Online publication date: 1-Jan-1998. Narayanan S and Hamasaki N (1998) Current Concepts of Coagulation and Fibrinolysis Advances in Clinical Chemistry Volume 33, 10.1016/S0065-2423(08)60207-3, (133-168), . Lengyel M, Fuster V, Keltai M, Roudaut R, Schulte H, Seward J, Chesebro J and Turpie A (1997) Guidelines for Management of Left-Sided Prosthetic Valve Thrombosis: A Role for Thrombolytic Therapy 11These guidelines are the results of a Consensus Conference held during the Symposium on Prosthetic Valve Thrombosis on September 16, 1994, in Budapest, Hungary., Journal of the American College of Cardiology, 10.1016/S0735-1097(97)00345-8, 30:6, (1521-1526), Online publication date: 1-Nov-1997. Schussheim A and Fuster V (1997) Thrombosis, antithrombotic agents, and the antithrombotic approach in cardiac disease, Progress in Cardiovascular Diseases, 10.1016/S0033-0620(97)80035-7, 40:3, (205-238), Online publication date: 1-Nov-1997. Ansell J, Buttaro M, Thomas O and Knowlton C (2016) Consensus Guidelines for Coordinated Outpatient Oral Anticoagulation Therapy Management, Annals of Pharmacotherapy, 10.1177/106002809703100516, 31:5, (604-615), Online publication date: 1-May-1997. HERMAN W, KONZELMAN J and SUTLEY S (1997) CURRENT PERSPECTIVES ON DENTAL PATIENTS RECEIVING COUMARIN ANTICOAGULANT THERAPY, The Journal of the American Dental Association, 10.14219/jada.archive.1997.0196, 128:3, (327-335), Online publication date: 1-Mar-1997. Peverill R, Harris G, Gelman J, Gan T, Harper R and Smolich J (1997) Effect of Warfarin on Regional Left Atrial Coagulation Activity in Mitral Stenosis, The American Journal of Cardiology, 10.1016/S0002-9149(96)00758-8, 79:3, (339-343), Online publication date: 1-Feb-1997. Higashikawa M, Nakamura Y, Yoshida M and Kinoshita M (1997) Incidence of Ischemic Strokes in Hypertrophic Cardiomyopathy is Markedly Increased if Complicated by Atrial Fibrillation, Japanese Circulation Journal, 10.1253/jcj.61.673, 61:8, (673-681), . Ripka W and Vlasuk G (1997) Chapter 8. Antithrombotics/Serine Proteases , 10.1016/S0065-7743(08)61466-9, (71-89), . Taube C (1997) Pharmaka mit Wirkung auf die Blutgerinnung Pharmakologie und Toxikologie, 10.1007/978-3-662-00487-6_26, (423-441), . Pauli R (1997) Anticoagulants Drug Toxicity in Embryonic Development II, 10.1007/978-3-642-60447-8_5, (191-229), . Völler H and Dovifat C (1997) Orale Langzeit-Antikoagulation: Indikation, Therapieeinleitung und Wertigkeit der INR-Selbstkontrolle Gerinnungsmanagement kardiovaskulärer Erkrankungen, 10.1007/978-3-642-48052-2_9, (95-101), . Maslow A, Breen T, Sarna M, Soni A, Watkins J and Oriol N (1996) Prevalence of coagulation abnormalities associated with intrauterine fetal death, Canadian Journal of Anaesthesia, 10.1007/BF03013432, 43:12, (1237-1243), Online publication date: 1-Dec-1996. Buck M (2016) Anticoagulation with Warfarin in Infants and Children, Annals of Pharmacotherapy, 10.1177/106002809603001117, 30:11, (1316-1322), Online publication date: 1-Nov-1996. Kadakia S, Angueira C, Ward J and Moore M (1996) Gastrointestinal endoscopy in patients taking antiplatelet agents and anticoagulants: survey of ASGE members, Gastrointestinal Endoscopy, 10.1016/S0016-5107(96)70170-0, 44:3, (309-316), Online publication date: 1-Sep-1996. WAHL M and HOWELL J (1996) ALTERING ANTICOAGULATION THERAPY: A SURVEY OF PHYSICIANS, The Journal of the American Dental Association, 10.14219/jada.archive.1996.0275, 127:5, (625-638), Online publication date: 1-May-1996. Almony G, Lefkovits J and Topol E (1996) Antiplatelet and anticoagulant use after myocardial infarction, Clinical Cardiology, 10.1002/clc.4960190506, 19:5, (357-365), Online publication date: 1-May-1996. Wahl M (1996) INR and PTR anticoagulation values, Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 10.1016/S1079-2104(96)80006-0, 81:4, (377-378), Online publication date: 1-Apr-1996. Forman R and Aronow W (1996) Management of Postmyocardial Infarction in the Elderly Patient, Clinics in Geriatric Medicine, 10.1016/S0749-0690(18)30251-9, 12:1, (169-180), Online publication date: 1-Feb-1996. Haines S and Bussey H (2016) Thrombosis and the Pharmacology of Antithrombotic Agents, Annals of Pharmacotherapy, 10.1177/106002809502900912, 29:9, (892-905), Online publication date: 1-Sep-1995. Massicotte P, Marzinotto V, Vegh P, Adams M and Andrew M (1995) Home monitoring of warfarin therapy in children with a whole blood prothrombin time monitor, The Journal of Pediatrics, 10.1016/S0022-3476(95)70069-2, 127:3, (389-394), Online publication date: 1-Sep-1995. Khamashta M, Cuadrado M, Mujic F, Taub N, Hunt B and Hughes G (1995) The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome, New England Journal of Medicine, 10.1056/NEJM199504133321504, 332:15, (993-997), Online publication date: 13-Apr-1995. BENEDINI G, MARCHINI A, CURNIS A, BIANCHETTI F, GARDINI A, PINETTI P and ZANELLI E (1995) Implantable Defibrillation and Thromboembolic Events, Pacing and Clinical Electrophysiology, 10.1111/j.1540-8159.1995.tb02504.x, 18:1, (199-202), Online publication date: 1-Jan-1995. Leuenberger K, Mileti I, Singh R and Bajpai P A hydroxyapatite ceramic matrix device for continuous delivery of coumadin 1995 Fourteenth Southern Biomedical Engineering Conference, 10.1109/SBEC.1995.514452, 0-7803-2083-2, (114-116) Vergnes C (1995) Surveillance des traitements antithrombotiques, Revue Française des Laboratoires, 10.1016/S0338-9898(95)80318-1, 1995:272, (89-99), Online publication date: 1-Jan-1995. Becker R (1995) Editorial: Toward establishing comprehensive universal guidelines for antithrombotic therapy, Journal of Thrombosis and Thrombolysis, 10.1007/BF01060731, 1:3, (225-229), . Skudicky D, Essop M, Wisenbaugh T, Skoularigis J, Essop A, Dullabh A, Bedhesi S, Strugo V and Sareli P (1994) Frequency of prosthetic valve-related complications with very low level warfarin anticoagulation combined with dipyridamole after valve replacement using St. Jude Medical prostheses, The American Journal of Cardiology, 10.1016/0002-9149(94)90467-7, 74:11, (1137-1141), Online publication date: 1-Dec-1994. Fuster V (1994) Lewis A. Conner Memorial Lecture. Mechanisms leading to myocardial infarction: insights from studies of vascular biology., Circulation, 90:4, (2126-2146), Online publication date: 1-Oct-1994. March 1, 1994Vol 89, Issue 3 Advertisement Article InformationMetrics Copyright © 1994 by American Heart Associationhttps://doi.org/10.1161/01.CIR.89.3.1469 Originally publishedMarch 1, 1994 PDF download Advertisement
Referência(s)